Letrozole is an easy to use inexpensive drug for the treatment of infertility. Concerns for the use of this drug seem to be unfounded according to a major study conducted by a research team from McGill University Health Centre (MUHC).
The research finding currently available in an early online edition of Fertility and Sterility, showed that babies whose mothers were treated with letrozole had the same rate of birth defects as those whose mothers were treated with clomiphene citrate – the low-risk, first-line treatment for infertility for more than 40 years.
This contradicts previous studies linking letrozole to increased rates of inherited malformations which led to widespread concern about the drug.
The study contradicts an earlier, much smaller study linking letrozole to increased rates of inherited malformations. This study led to widespread concern about the use of letrozole, a drug which has been widely used in the treatment of infertility in recent years.
Source: EurekAlert
.jpg)
Comment Preview